A Novel Pathogenic Variant in RTEL1 Causes Dyskeratosis Congenita/Hoyeraal-Hreidarsson Syndrome: A Report of Two Cases

Background: Telomere biology disorders (TBD) are a spectrum of conditions that result from shortened or dysfunctional telomeres. Dyskeratosis congenita (DC) is the prototypic TBD, classically presenting with leukoplakia, dysplastic nails, and reticular skin pigmentation. Immunologic abnormalities are common, and severe infection may be the presenting sign of DC. RTEL1 gene mutations are known to cause DC and are associated with a severe disease phenotype (Hoyeraal-Hreidarsson syndrome). Observation: In this report, we describe 2 patients with severe immunodeficiency and very early onset inflammatory bowel disease found to have novel homozygous mutations in RTEL1 (c.1670T>C, p.L557P). Conclusion: The clinical presentation of these 2 patients with the same novel mutation suggests this mutation is pathogenic and causative of TBD.

Authors

Institutions

Publication Details

Journal
Journal of Pediatric Hematology/Oncology
Published
2026-09-30
DOI
https://doi.org/10.1097/mph.0000000000003276
Primary Topic
Telomeres, Telomerase, and Senescence
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

A Novel Pathogenic Variant in RTEL1 Causes Dyskeratosis Congenita/Hoyeraal-Hreidarsson Syndrome: A Report of Two Cases

Jonathan D. Fish, Adrianna Vlachos, Alexandra M. Satty, Michelle Nash et al.
Journal of Pediatric Hematology/Oncology
Telomeres, Telomerase, and Senescence
article

A Novel Pathogenic Variant in RTEL1 Causes Dyskeratosis Congenita/Hoyeraal-Hreidarsson Syndrome: A Report of Two Cases

Jonathan D. Fish, Adrianna Vlachos, Alexandra M. Satty, Michelle Nash, Ariella Reiter, Susan Schuval, Michael Kho
article en

Abstract

Background: Telomere biology disorders (TBD) are a spectrum of conditions that result from shortened or dysfunctional telomeres. Dyskeratosis congenita (DC) is the prototypic TBD, classically presenting with leukoplakia, dysplastic nails, and reticular skin pigmentation. Immunologic abnormalities are common, and severe infection may be the presenting sign of DC. RTEL1 gene mutations are known to cause DC and are associated with a severe disease phenotype (Hoyeraal-Hreidarsson syndrome). Observation: In this report, we describe 2 patients with severe immunodeficiency and very early onset inflammatory bowel disease found to have novel homozygous mutations in RTEL1 (c.1670T>C, p.L557P). Conclusion: The clinical presentation of these 2 patients with the same novel mutation suggests this mutation is pathogenic and causative of TBD.

Journal of Pediatric Hematology/Oncology
Northwell Health (US), Hofstra University (US), Johns Hopkins All Children's Hospital (US), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US), Cohen Children's Medical Center (US), Stony Brook Children's Hospital (US), Stony Brook University (US)
Good health and well-being
Openalex Percentile: Top 12%
Telomeres, Telomerase, and Senescence
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Novel Pathogenic Variant in RTEL1 Causes Dyskeratosis Congenita/Hoyeraal-Hreidarsson Syndrome: A Report of Two Cases — Jonathan D. Fish, Adrianna Vlachos, et al. · Journal of Pediatric Hematology/Oncology (2026) | TGRS Research Map | TGRS